Affiliation:
1. Department of Cell and Chemical Biology, Oncode Institute Leiden University Medical Center Leiden The Netherlands
2. Current: Institute of Biology Leiden Leiden University Leiden The Netherlands
3. Department of Chemistry Norwegian University of Science and Technology Trondheim Norway
Subject
Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience
Reference92 articles.
1. Advances in covalent kinase inhibitors
2. Considerations for the design and reporting of enzyme assays in high-throughput screening applications
3. Assay Guidance Manual(2004‐2021).Eli Lilly & Company and the National Center for Advancing Translational Sciences.http://www.ncbi.nlm.nih.gov/books/NBK53196/.
4. Auld D. S. Inglese J. &Dahlin J. L.(2017).Assay Interference by Aggregation. InAssay Guidance Manual [Internet]. Eli Lilly & Company and the National Center for Advancing Translational Sciences. Available athttps://www.ncbi.nlm.nih.gov/books/NBK442297/.
5. Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献